INNOVATE Corp. Reports Q3 2026 Revenue of $495.5 Million and Announces MediBeacon Shipment Outlook
INNOVATE Corp. (VATE) reported consolidated revenues of $495.5 million and an adjusted EBITDA of $40.5 million for the third quarter of 2026. Following the sale of DBM Global, the company has provided updated guidance regarding its medical technology segment. The company outlined a shipment plan for 600 MediBeacon TGFR monitors, with deliveries expected to continue through the second quarter of 2027. This strategic shift follows recent divestitures aimed at refining the company's operational focus.
Topics: EBITDA Q3 Earnings Revenue